| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
SOUTH SAN FRANCISCO, Calif. & PORTLAND, Ore.—The beginning of November saw Sirona Dx, a company involved in high-complexity genomics and proteomics services, announce the introduction of imaging mass cytometry services on the Fluidigm Hyperion Imaging System to advance biomarker discovery and therapeutic development.
 
Specifically, Sirona Dx is a specialized contract research organization (CRO) that provides high-quality clinical research services to pharmaceutical and clinical research clients and focuses on offering early access to advanced technologies. With a goal of providing innovative approaches to expand drug discovery pipelines and bring more effective therapies to market, the company decided to add multiplex tissue imaging to its growing technology portfolio.
 
As part of this effort, and having noted “impressive imaging mass cytometry results from top pharmaceutical companies and leading academic medical centers,” Sirona Dx engaged Dr. Akil Merchant, an assistant professor at the University of Southern California Keck School of Medicine, as a scientific advisor to assess its full potential.
 
“After a comprehensive evaluation of different tissue imaging technologies, imaging mass cytometry was the clear choice. Imaging mass cytometry will enable our clients to resolve complex cellular networks and signaling pathways within tissue microenvironments with unprecedented definition,” said Dr. Nasry Yassa, CEO of Sirona Dx. “The early response from our pharma partners has been extremely positive. Our clients are expressing significant interest in using imaging mass cytometry to advance their research goals and are pleased to access this new technology through an experienced CRO. Sirona Dx has exciting projects underway and additional requests coming in from top pharmaceutical companies.”
 
Developed for research use, imaging mass cytometry enables simultaneous imaging of up to 37 protein markers from a single scan of formalin-fixed, paraffin-embedded or fresh tissue sections at subcellular resolution. Using CyTOF technology, imaging mass cytometry reportedly surpasses the inherent limitations of fluorescence detection by using high-purity metal tags that are separated by mass instead of by wavelength—according to Sirona Dx, with “an established global footprint and 18 scientific publications to date, imaging mass cytometry is rapidly setting a new standard for highly multiplexed tissue imaging.”
 
“By preserving tissue architecture and cellular morphology information, imaging mass cytometry is ideal for understanding complex tissue microenvironments. It is especially useful for monitoring changes in the immune system in a variety of disease states such as cancer or auto-immunity,” said Merchant. “With easily customizable panel designs using available pre-conjugated antibodies or metal conjugation kits, imaging mass cytometry is a valuable tool for translational and clinical research across a range of disease areas.”
 
“Sirona Dx is our first imaging mass cytometry CRO partner in the United States,” said Chris Linthwaite, president and CEO of Fluidigm. “Expanding market accessibility is a top priority for unlocking the full potential of imaging mass cytometry. CRO partners play a critical role in providing valuable expertise, accelerating new health insights.”

Related Topics

Published In

Volume 14 - Issue 12 | December 2018

December 2018

December 2018 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A doctor wearing blue gloves and a white lab coat with a stethoscope around their neck holds a rendering of a digestive system on a glass pane with a swirled blue background.

Connecting the gut and liver to enhance drug development

Explore how a dual-organ microphysiological system connects human gut and liver tissue to bridge gaps in predicting how drugs behave in the body.
A syringe draws liquid from a glass vial, with several glass ampoules reflected on a glossy surface in the background

Turning up the heat: thermal analysis for biotherapeutics

Explore essential thermal stability techniques to ensure the safety, quality, and efficacy of biologic drugs.
A 3D-rendered image of a pink and white twisted RNA strand floating against a green, blurred cellular background.

Cutting the time and cost out of plasmid generation

Discover a hassle-free path to obtaining long, complex plasmid DNA.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue